CoChat

Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD

Open access
Kim, Beom Kyung, Tamaki, Nobuharu, Imajo, Kento, Yoneda, Masato, Sutter, Nancy, Jung, Jinho, Lin, Tuo, Tu, Xin M., Bergstrom, Jaclyn, Nguyen, Khang, Nguyen, Leyna, Le, Tracy, Madamba, Egbert, Richards, Lisa, Valasek, Mark A., Behling, Cynthia, Sirlin, Claude B., Nakajima, Atsushi, Loomba, Rohit · 2022 · Journal of Hepatology
Cited by 106

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIM Nonalcoholic fatty liver disease (NAFLD) patients with significant fibrosis (fibrosis stage ≥2) are candidates for pharmacological trials. The aim of this study was to examine head to head comparison between the diagnostic test characteristics of three non-invasive stiffness-based models including MEFIB (magnetic resonance elastography [MRE] plus FIB-4), MAST (magnetic resonance imaging [MRI]-aspartate aminotransferase [AST]), and FAST (FibroScan-AST) for detecting significant fibrosis. METHODS This prospective study included 563 biopsy-proven NAFLD patients undergoing contemporaneous MRE, MRI proton density fat fraction (MRI-PDFF) and FibroScan from two prospective cohorts derived from Southern California and Japan. Diagnostic performances of models were evaluated by area under the receiver operating characteristic (AUROC). RESULTS The mean age was 56.5 years (51% Women). Significant fibrosis was observed in 51.2%. To detect significant fibrosis, MEFIB outperformed both MAST and FAST (both p<0.001); AUROCs for MEFIB, MAST, and FAST were 0.901 (95% confidence interval [CI]: 0.875 - 0.928), 0.770 (95% CI: 0.730 - 0.810), and 0.725 (95% CI: 0.683 - 0.767), respectively. Using rule-in criteria, positive predictive value of MEFIB (95.3%) was significantly higher than FAST (83.5%, p=0.001), but numerically higher but not statistically greater than MAST (90.0%, p=0.056). Notably, MEFIB's rule-in criteria covered more of the study population than MAST (34.1% vs. 26.6%; p=0.006). Using rule-out criteria, negative predictive value of MEFIB (90.1%) was significantly higher than either MAST (69.6%) or FAST (71.8%) (both p<0.001). Furthermore, to diagnose "at risk" nonalcoholic steatohepatitis defined as NAFLD activity score ≥ 4 and fibrosis stage ≥ 2, MEFIB outperformed both MAST and FAST (both p<0.05); AUROCs for MEFIB, MAST, and FAST were 0.768 (95% CI: 0.728 - 0.808), 0.719 (95% CI: 0.671 - 0.766), and 0.687 (95% CI: 0.640 - 0.733), respectively. CONCLUSIONS MEFIB was better than MAST and FAST for detection of significant fibrosis as well as "at risk" NASH. All three models provide utility in risk stratification of NAFLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.07.020

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 106

Metadata

Authors
Kim, B. K., Tamaki, N., Imajo, K., Yoneda, M., Sutter, N., Jung, J., Lin, T., Tu, X. M., Bergstrom, J., Nguyen, K., Nguyen, L., Le, T., Madamba, E., Richards, L., Valasek, M. A., Behling, C., Sirlin, C. B., Nakajima, A., & Loomba, R.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2022-12
Volume
77
Issue
6
Pages
1482-1490
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4291710776
Cited by
106
References
15
FWCI
13.78
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.